244 related articles for article (PubMed ID: 26183924)
1. Immunosuppressive and Prometastatic Functions of Myeloid-Derived Suppressive Cells Rely upon Education from Tumor-Associated B Cells.
Bodogai M; Moritoh K; Lee-Chang C; Hollander CM; Sherman-Baust CA; Wersto RP; Araki Y; Miyoshi I; Yang L; Trinchieri G; Biragyn A
Cancer Res; 2015 Sep; 75(17):3456-65. PubMed ID: 26183924
[TBL] [Abstract][Full Text] [Related]
2. Tumor-infiltrating monocytic myeloid-derived suppressor cells mediate CCR5-dependent recruitment of regulatory T cells favoring tumor growth.
Schlecker E; Stojanovic A; Eisen C; Quack C; Falk CS; Umansky V; Cerwenka A
J Immunol; 2012 Dec; 189(12):5602-11. PubMed ID: 23152559
[TBL] [Abstract][Full Text] [Related]
3. A major role for myeloid-derived suppressor cells and a minor role for regulatory T cells in immunosuppression during Staphylococcus aureus infection.
Tebartz C; Horst SA; Sparwasser T; Huehn J; Beineke A; Peters G; Medina E
J Immunol; 2015 Feb; 194(3):1100-11. PubMed ID: 25548227
[TBL] [Abstract][Full Text] [Related]
4. Subsets of myeloid-derived suppressor cells in tumor-bearing mice.
Youn JI; Nagaraj S; Collazo M; Gabrilovich DI
J Immunol; 2008 Oct; 181(8):5791-802. PubMed ID: 18832739
[TBL] [Abstract][Full Text] [Related]
5. Subpopulations of myeloid-derived suppressor cells impair T cell responses through independent nitric oxide-related pathways.
Raber PL; Thevenot P; Sierra R; Wyczechowska D; Halle D; Ramirez ME; Ochoa AC; Fletcher M; Velasco C; Wilk A; Reiss K; Rodriguez PC
Int J Cancer; 2014 Jun; 134(12):2853-64. PubMed ID: 24259296
[TBL] [Abstract][Full Text] [Related]
6. Regulatory B cells in anti-tumor immunity.
Zhang Y; Gallastegui N; Rosenblatt JD
Int Immunol; 2015 Oct; 27(10):521-30. PubMed ID: 25999597
[TBL] [Abstract][Full Text] [Related]
7. Tumor-Promoting Effects of Myeloid-Derived Suppressor Cells Are Potentiated by Hypoxia-Induced Expression of miR-210.
Noman MZ; Janji B; Hu S; Wu JC; Martelli F; Bronte V; Chouaib S
Cancer Res; 2015 Sep; 75(18):3771-87. PubMed ID: 26206559
[TBL] [Abstract][Full Text] [Related]
8. MIF Is Necessary for Late-Stage Melanoma Patient MDSC Immune Suppression and Differentiation.
Yaddanapudi K; Rendon BE; Lamont G; Kim EJ; Al Rayyan N; Richie J; Albeituni S; Waigel S; Wise A; Mitchell RA
Cancer Immunol Res; 2016 Feb; 4(2):101-12. PubMed ID: 26603621
[TBL] [Abstract][Full Text] [Related]
9. Defective TGF-β signaling in bone marrow-derived cells prevents hedgehog-induced skin tumors.
Fan Q; Gu D; Liu H; Yang L; Zhang X; Yoder MC; Kaplan MH; Xie J
Cancer Res; 2014 Jan; 74(2):471-483. PubMed ID: 24282281
[TBL] [Abstract][Full Text] [Related]
10. Melanoma-educated CD14+ cells acquire a myeloid-derived suppressor cell phenotype through COX-2-dependent mechanisms.
Mao Y; Poschke I; Wennerberg E; Pico de Coaña Y; Egyhazi Brage S; Schultz I; Hansson J; Masucci G; Lundqvist A; Kiessling R
Cancer Res; 2013 Jul; 73(13):3877-87. PubMed ID: 23633486
[TBL] [Abstract][Full Text] [Related]
11. Yeast-Derived Particulate β-Glucan Treatment Subverts the Suppression of Myeloid-Derived Suppressor Cells (MDSC) by Inducing Polymorphonuclear MDSC Apoptosis and Monocytic MDSC Differentiation to APC in Cancer.
Albeituni SH; Ding C; Liu M; Hu X; Luo F; Kloecker G; Bousamra M; Zhang HG; Yan J
J Immunol; 2016 Mar; 196(5):2167-80. PubMed ID: 26810222
[TBL] [Abstract][Full Text] [Related]
12. Myeloid-derived suppressor cells attenuate TH1 development through IL-6 production to promote tumor progression.
Tsukamoto H; Nishikata R; Senju S; Nishimura Y
Cancer Immunol Res; 2013 Jul; 1(1):64-76. PubMed ID: 24777249
[TBL] [Abstract][Full Text] [Related]
13. Adoptive cytotoxic T lymphocyte therapy triggers a counter-regulatory immunosuppressive mechanism via recruitment of myeloid-derived suppressor cells.
Hosoi A; Matsushita H; Shimizu K; Fujii S; Ueha S; Abe J; Kurachi M; Maekawa R; Matsushima K; Kakimi K
Int J Cancer; 2014 Apr; 134(8):1810-22. PubMed ID: 24150772
[TBL] [Abstract][Full Text] [Related]
14. The Granulocyte Progenitor Stage Is a Key Target of IRF8-Mediated Regulation of Myeloid-Derived Suppressor Cell Production.
Netherby CS; Messmer MN; Burkard-Mandel L; Colligan S; Miller A; Cortes Gomez E; Wang J; Nemeth MJ; Abrams SI
J Immunol; 2017 May; 198(10):4129-4139. PubMed ID: 28356386
[TBL] [Abstract][Full Text] [Related]
15. Tumor-induced myeloid-derived suppressor cell subsets exert either inhibitory or stimulatory effects on distinct CD8+ T-cell activation events.
Schouppe E; Mommer C; Movahedi K; Laoui D; Morias Y; Gysemans C; Luyckx A; De Baetselier P; Van Ginderachter JA
Eur J Immunol; 2013 Nov; 43(11):2930-42. PubMed ID: 23878002
[TBL] [Abstract][Full Text] [Related]
16. Anti-CD20 antibody promotes cancer escape via enrichment of tumor-evoked regulatory B cells expressing low levels of CD20 and CD137L.
Bodogai M; Lee Chang C; Wejksza K; Lai J; Merino M; Wersto RP; Gress RE; Chan AC; Hesdorffer C; Biragyn A
Cancer Res; 2013 Apr; 73(7):2127-38. PubMed ID: 23365136
[TBL] [Abstract][Full Text] [Related]
17. IFN regulatory factor 8 represses GM-CSF expression in T cells to affect myeloid cell lineage differentiation.
Paschall AV; Zhang R; Qi CF; Bardhan K; Peng L; Lu G; Yang J; Merad M; McGaha T; Zhou G; Mellor A; Abrams SI; Morse HC; Ozato K; Xiong H; Liu K
J Immunol; 2015 Mar; 194(5):2369-79. PubMed ID: 25646302
[TBL] [Abstract][Full Text] [Related]
18. Transmembrane TNF-α promotes suppressive activities of myeloid-derived suppressor cells via TNFR2.
Hu X; Li B; Li X; Zhao X; Wan L; Lin G; Yu M; Wang J; Jiang X; Feng W; Qin Z; Yin B; Li Z
J Immunol; 2014 Feb; 192(3):1320-31. PubMed ID: 24379122
[TBL] [Abstract][Full Text] [Related]
19. Tumor conditions induce bone marrow expansion of granulocytic, but not monocytic, immunosuppressive leukocytes with increased CXCR2 expression in mice.
Bian Z; Shi L; Venkataramani M; Abdelaal AM; Culpepper C; Kidder K; Liang H; Zen K; Liu Y
Eur J Immunol; 2018 Mar; 48(3):532-542. PubMed ID: 29120053
[TBL] [Abstract][Full Text] [Related]
20. Blockade of Myd88 signaling induces antitumor effects by skewing the immunosuppressive function of myeloid-derived suppressor cells.
Hong EH; Chang SY; Lee BR; Kim YS; Lee JM; Kang CY; Kweon MN; Ko HJ
Int J Cancer; 2013 Jun; 132(12):2839-48. PubMed ID: 23184679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
